For abnormal laboratory indicators, the increase in PTH and intact FGF23 levels with a reduction in 1,25-(OH)2-D3 levels in patients with CKD could indicate a disorder of renal function, glomerular filtration function, and renal phosphate excretion in CKD–MBD [29–31]. This evidence concerns the gene FGF23 and chronic kidney disease.